Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions.

Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. Abstract Text:

BACKGROUND: Bone metastasis is the most common cause of morbidity and mortality in patients with advanced prostate cancer and is manifested primarily as mixed osteoblastic and osteolytic lesions. However, the mechanisms responsible for bone metastases in prostate cancer are not clearly understood, in part due to the lack of relevant in vivo models that mimic the clinical presentation of the disease in humans. We previously established a nude mouse model with mixed bone metastases using intracardiac injection of canine prostate cancer cells (Ace-1). In this study, we hypothesized that tumor-induced osteolysis promoted the incidence of bone metastases and osteoblastic activity. METHODS: We studied the effect of inhibition of osteolysis with zoledronic acid (ZA) on the prevention and progression of Ace-1 bone metastases in nude mice using prophylactic and delayed treatment protocols. Bioluminescent imaging, radiography, and histopathological evaluation were performed to monitor the effect of ZA on the incidence, progression and nature of bone metastases. RESULTS: Unexpectedly, there was no significant difference in tumor burden and the incidence of metastasis between control and treatment groups as detected by bioluminescent imaging and bone histomorphometry. However, radiographic and histopathological analysis showed a significant treatment-related decrease in osteolysis, but no effect on tumor-induced trabecular bone thickness in both treatment groups compared to controls. CONCLUSION: Our results demonstrated that the incidence of prostate cancer bone metastases in vivo was not reduced by zoledronic acid even though zoledronic acid inhibited bone resorption and bone loss associated with the mixed osteoblastic/osteolytic bone metastases in the Ace-1 model. Prostate 68: 1116-1125, 2008. (c) 2008 Wiley-Liss, Inc.

Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Prostate

VOLUME: 68

Page Numbers: 1116-25

Journal Abbreviation: Prostate

ISSN: 0270-4137

DAY: 1

MONTH: Jul

YEAR: 2008

Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8101368

Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions.

AFFILIATION: Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Prostate

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions Related Publications

• A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma.
• A novel canine lymphoma cell line: a translational and comparative model for lymphoma research.
• Expression of parathyroid hormone-related protein during immortalization of human peripheral blood mononuclear cells by HTLV-1: Implications for transformation.
• Histopathologic and gross effects of testicular biopsy in the dog.
• Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases.
• The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice.
• Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions.
• [SOVIET AUTOMAT AT 3 IN THE CYTOLOGICAL LABORATORY.]
• [The role of Herpes virus hominis 2 in the genesis of cervical carcinoma]